Clinical Trials Logo

Myalgia clinical trials

View clinical trials related to Myalgia.

Filter by:

NCT ID: NCT01274104 Withdrawn - Hyperlipidemia Clinical Trials

A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia

Start date: October 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to measure the effect vitamin D has in alleviating muscle pain or aches that may be caused by taking certain medications for treating high cholesterol.

NCT ID: NCT01271348 Completed - Muscle Pain Clinical Trials

Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

Start date: January 2011
Phase: Phase 1
Study type: Interventional

Comparison of the effect of etoricoxib to placebo on muscle pain caused by eccentric contractions

NCT ID: NCT01211717 Completed - Type 2 Diabetes Clinical Trials

The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients

Start date: October 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of the 3 Branched Chained Amino Acids (isoleucine, leucine, and valine) on treating Delayed Onset Muscle Soreness, a type of muscle pain which usually develops after exercising.

NCT ID: NCT01163682 Completed - Breast Cancer Clinical Trials

Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy

Start date: December 2010
Phase: N/A
Study type: Interventional

This study seeks to determine if 12 weeks of weekly electro-acupuncture will prevent or decrease neuropathic pain in breast cancer patients receiving 12 weekly treatments of taxane treatment.

NCT ID: NCT01156922 Terminated - Clinical trials for Chronic Fatigue Syndrome

B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome

Start date: June 2010
Phase: Phase 2
Study type: Interventional

Based on pilot patient observations, and experience from the prior study KTS-1-2008, the investigators anticipate that severely affected chronic fatigue syndrome patients may benefit from B-cell depletion therapy using Rituximab induction with maintenance treatment. The hypothesis is that at least a subset of chronic fatigue syndrome (CFS) patients have an activated immune system involving B-lymphocytes, and that prolonged B-cell depletion may alleviate symptoms. An approved amendment (April 15th 2011): the study will be extended with up to 5 patients. For up to 5 patients in the study, standard plasma exchange may be performed 2-3 weeks prior to start of B-lymphocyte depletion using Rituximab (as in the protocol). Approved amendment (December 2011): for patients with gradual improvement in CFS/ME symptoms after 12 months follow-up, but not having reached a clear response, up to 6 additional Rituximab infusions (500 mg/m2, max 1000 mg) may be given during the following 12 months period.

NCT ID: NCT01097798 Not yet recruiting - Trauma Clinical Trials

To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.

LBB-ALI-01/09
Start date: June 2010
Phase: Phase 3
Study type: Interventional

Multicenter, randomized, double-blind trial, to evaluate the efficacy and safety Aliviador compared to Gelol in the relief of signs and symptoms in patients with contusions, sprains, trauma and muscle injury start with less than 24 hours or patients of myalgia, myofascial pain and tendinitis.

NCT ID: NCT01032993 Active, not recruiting - Pain Clinical Trials

Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms

Start date: December 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate whether a dietary supplement, coenzyme Q10 (CoQ10), will improve muscle symptoms, such as muscle aches, pains, cramps, and/or weakness, which are experienced by some individuals who use statin medications.

NCT ID: NCT01026311 Completed - Muscle Weakness Clinical Trials

Coenzyme Q10 in Older Athletes Treated With Statin Medications

Start date: November 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effect of coenzyme Q10 administration in improving mitochondrial function as measured by anaerobic threshold in older athletes on a stable dose of statin medication.

NCT ID: NCT01022398 Terminated - Clinical trials for HMG-CoA Reductase Inhibitors-related Myalgias

Vitamin D Replacement: The Effect on Statin-Related Myalgias

Start date: February 2010
Phase: N/A
Study type: Interventional

The purpose of this project is to determine if Vitamin D supplementation [10,000 international units of cholecalciferol (vitamin D3) by mouth weekly] will decrease the rate of discontinuation of statin therapy due to muscle ache/pain and decrease the occurrence of muscle ache/pain due to statin therapy.

NCT ID: NCT01020279 Completed - Clinical trials for Musculoskeletal Pain

Study of Epicutaneously Applied Ketoprofen Transfersome® Gel With or Without Combination With Oral Celecoxib for the Treatment of Muscle Pain Induced by Eccentric Exercise

Start date: October 2009
Phase: Phase 1
Study type: Interventional

1. Comparison of the effect of ketoprofen Transfersome® gel (KTG) to placebo gel (PG) on muscle pain of the calf caused by eccentric contractions 2. Comparison of the effect of KTG to celecoxib (CE) on muscle pain of the calf caused by eccentric contractions 3. Comparison of the effect of celecoxib (CE) to oral placebo (OP) on muscle pain of the calf caused by eccentric contractions